Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6155929 | Translational Research | 2016 | 14 Pages |
Abstract
Vaccines hold promise both for the prevention of infections and as potential immunologic therapy for patients with autoimmune disease (AD). These patients are at high risk for both common and opportunistic infections, but this risk can be significantly reduced and even obviated with the use of recommended available vaccines. Unfortunately, patients with ADs are not routinely offered or provided indicated vaccinations and have higher rates of complications from vaccine-preventable illnesses than patients without ADs. In addition, vaccine therapy is currently under study for the treatment of autoimmune disorders, with early studies demonstrating immunomodulatory effects that may counter undesired immune activation and alleviate disease activity.
Keywords
TGFTCVTNFT-cell vaccinationPCPIBDGBSACRIL-10EAEMMRVMMRCAPITAthe European League Against RheumatismTdapPCV13ImmunosuppressiveSLEDAIAPLSEULARIgGRNPIgMANCAPBVCDCMBPPneumocystis pneumoniaRheumatoid arthritisAsiaexperimental autoimmune encephalomyelitisRNAribonucleic acidimmunoglobulin Gimmunoglobulin MInterleukin 10Autoimmune diseaseInflammatory bowel diseaseACIPtransforming growth factorDiabetes mellitusribonucleoproteinHerpes zosterDendritic cellGuillain–Barré syndromesystemic lupus erythematosus disease activity indextumor necrosis factorSystemic lupus erythematosusSLEaltered peptide ligandsCenters for Disease Control and PreventionMultiple sclerosisHBVHibhuman immunodeficiency virusHIVhepatitis B virusHuman papillomavirusHPVMyelin basic proteinVaccine efficacyAmerican College of RheumatologyAdvisory Committee on Immunization Practices
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
John E. McKinnon, Kathleen Maksimowicz-McKinnon,